Isogenica’s Blogs

Unlocking Affordable Biologics: VHH Antibodies in Baker’s Yeast

Unlocking Affordable Biologics: VHH Antibodies in Baker’s Yeast

The production of traditional IgG monoclonal antibodies has long been hindered by their complexity. These molecules require complex and costly manufacturing processes, with estimated production costs ranging from $95 to $200 per gram. As well as contributing to issues...

Synthetic Biology Technologies for Antibody Discovery

Synthetic Biology Technologies for Antibody Discovery

Imagine bypassing the lengthy traditional immunization process and tapping into the antibody diversity equivalent of over a million llamas – right at your fingertips. Synthetic Biology Technologies are transforming antibody discovery, accelerating the design of targeted therapies with greater precision, speed, and reduced risk. Read now!

Nanobody or VHH – What’s the difference?

Nanobody or VHH – What’s the difference?

In the realm of biotechnology and medicine, the terms nanobody and VHH are often used interchangeably to describe single-domain antibodies. These small-format versions of traditional antibodies have grown as cornerstones of scientific innovation from diagnostics to cell and gene therapies. But where do these names come from, and what meanings do they have for describing what makes them so pivotal in today’s research and therapeutic applications? 

Contact us